Signalling pathways leading to IFN-α production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications-Reference-Cited by-同舟云学术

Signalling pathways leading to IFN-α production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications

Published:2009-01 Issue:1 Volume:265 Page:43-57
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:

Author:

Guiducci C.,Coffman R. L.,Barrat F. J.

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2796.2008.02050.x/fullpdf

Reference102 articles.

1. Dendritic cell lineage, plasticity and cross-regulation;Liu;Nat Immunol,2001

2. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases;Gilliet;Nat Rev Immunol,2008

3. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors;Liu;Annu Rev Immunol,2005

4. Production of type I interferons: plasmacytoid dendritic cells and beyond;Asselin-Paturel;J Exp Med,2005

5. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice;Santini;J Exp Med,2000

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon-I modulation and natural products: Unraveling mechanisms and therapeutic potential in severe COVID-19;Cytokine & Growth Factor Reviews;2024-08

2. Modulation of Unregulated Inflammation‐Associated Coagulopathy in Sepsis Using Multifunctional Nanosheets;Advanced Functional Materials;2024-05-02

3. 3,3′-Diindolylmethane inhibits Th17 cell differentiation via impairing IRF-7-mediated plasmacytoid dendritic cell activation in imiquimod-induced psoriasis mice;In Vitro Cellular & Developmental Biology - Animal;2024-04-11

4. The mechanism of Langchuangding in treatment of systemic lupus erythematosus via modulating TLR7-IRF7-IFNα pathway;Heliyon;2024-03

5. The scientific journey of a novel adjuvant (AS37) from bench to bedside;npj Vaccines;2024-02-08